Confirmed Sponsors & Exhibitors
Our current sponsors and exhibitors
On any given day, 2.5 billion people use Unilever products. Our range of more than 400 brands give us a unique place in the lives of people all over the world. Seven out of every ten households around the world contain at least one Unilever product, and our range of world-leading, household-name brands includes Dove, Knorr, Lipton, Axe, Hellmann’s and Omo. Unilever’s purpose and business strategy are to make sustainable living commonplace.
We use a wide range of non-animal approaches to assess the safety of our products for consumers. We are committed to ending animal testing. Our leading-edge research has one clear purpose: to continue to develop new non-animal approaches that can guarantee that our products are safe, without any need for animal testing. As part of our commitment to ending animal testing, we have a growing number of brands that ensure that neither their products – nor the ingredients they use – are subject to animal testing by suppliers or by regulatory authorities. These brands’ commitment to no animal testing is certified by animal welfare groups.
Our commitment to ending animal testing is under-pinned by our work since the 1980s in developing and using alternatives to animal tests for assessing safety, e.g. computer-based modelling and cell-based ‘in vitro’ methods. Unilever’s framework for safety assessment is risk-based rather than hazard-based. This enables us to use a wide range of non-animal approaches to assess the safety of our products for consumers. We are making good progress in developing next generation (non-animal) risk assessment approaches for assessing new ingredients and share our scientific research on a dedicated
Safety Science in the 21st Century website.
L’Oréal has devoted itself to beauty for over 100 years. With its unique international portfolio of diverse and complementary brands, the Group generated sales amounting to 26.9 billion euros in 2018 and employs 82 000 people worldwide.
Research & Innovation, and a dedicated research team of 3 993 people, are at the core of L’Oréal’s strategy, working to meet beauty aspirations all over the world. L’Oréal’s sustainability commitment for 2020 “Sharing Beauty With All” sets out ambitious sustainable development objectives across the Group’s value chain.
Consumer health and safety is and has always been an absolute priority of the L’Oréal Group. Defending animals’ welfare as well. To achieve these two objectives, L’Oréal conducts a very strict safety evaluation policy for its products. Starting by the development of the first models of reconstructed skins in 2019, L’Oréal has been a pioneer in the development and use of new alternative in vitro and in silico methods.
Thanks to this long term investment and conviction , L’Oréal stopped testing its products on animals in 1989, 14 years before required to do so by law. L’Oréal no longer tests its ingredients on animals neither tolerates any exceptions to this rule.
L’Oréal’s commitment to ending animal testing is supported by the provision of reconstructed skin models thanks to 3 production Units through its subsidiary EPISKIN SA (based in France, China, Brazil), the development and validation of new alternative methods and the sharing of its scientific advances.
In 2017, the OECD adopted two new alternatives methods developed by the L’Oréal Research Laboratories, to evaluate skin allergy and eye irritation. Today, L’Oréal is committed to develop next generation of new safety assessment approaches alternative to animal testing to ensure product safety for consumers and environment and support innovation.
Our brands are trusted everyday in millions of living rooms, kitchens, laundry rooms, and bathrooms – and have been family favorites from generation to generation for over 180 years. We know that to continue to be the brands people choose, we must continue to innovate high quality and safe ingredients. We also recognize that we must continue to evolve our approach to demonstrating safety.
We are committed to making animal testing obsolete. For more than 40 years, P&G has engaged in non-animal approaches and solutions. We have sponsored and contributed to all World Congresses on Animal Alternatives, including the first held in 1993 in Baltimore, Maryland. Over that time, P&G has invested more than $420 million in developing non-animal alternatives, yielding more than 25 alternative test assays invented or co-invented by our experts. Many of these approaches have been accepted as the new standard in non-animal safety assessment used by academia, industry or regulatory authorities around the world. Some of them, like the Direct Peptide Reactivity Assay (DPRA), have been recognized with prestigious awards by animal welfare groups.
Yet there is more to be done. Therefore, we are a proud sponsor of #BeCrueltyFree, calling for an end to all animal testing of cosmetic products globally.
And we are pleased to sponsor the 11th World Congress to enable the sharing and reapplication of the latest progress in non-animal alternatives. Let’s work together, because only together can we make our shared goal a reality: Making animal testing obsolete.
More information will be added soon.
Humane Society International works to create a kinder, more humane world for all animals through science, education, advocacy and policy change. Our Research & Toxicology team includes scientists, regulatory and government affairs professionals who are active on the ground in the world’s leading innovation economies. We work with industry and lawmakers to enact legislation that reduces reliance on animal testing in favor of best scientific practice and to implement bans on animal testing of cosmetics (hsi.org/becrueltyfree). We work with regulatory authorities and stakeholders to accelerate regulatory acceptance of animal-free safety assessment practices across multiple industry sectors (animalfreesafety.org). Our team also leads the BioMed21 Collaboration (biomed21.org) to move medical research to embrace 21st century science.
Beiersdorf is a leading provider of innovative, high-quality skin care products and has over 135 years of experience in this market segment. The Hamburg-based company has about 20,000 employees worldwide and is listed on the DAX, the German benchmark equities index. Beiersdorf generated sales of €7.2 billion in financial year 2018. Its product portfolio comprises strong, international leading skin and body care brands including NIVEA, Eucerin, Hansaplast/Elastoplast, and La Prairie.
The European Partnership for Alternative Approaches to Animal Testing (EPAA) is an unprecedented voluntary collaboration between the European Commission, European trade associations, and companies from 7 industry sectors.
The partners are committed to pooling knowledge and resources to accelerate the development, validation and acceptance of alternative approaches to animal use in regulatory testing. The overall aim is the replacement, reduction and refinement (3Rs) of animal use in regulatory testing.
The International Fragrance Association (IFRA) is the representative body of the fragrance industry worldwide. Comprised of eight multinational companies, hundreds of small and medium-sized companies in 21 National Associations, and eight supporting members, IFRA’s membership covers about 90% of the industry by production volume. We seek to promote the safe use of fragrance for everyone’s enjoyment, working with regulators and promoting our flagship self-regulatory program, the IFRA Code of Practice and the IFRA Standards.
The Humane Society of the United States is working tirelessly to decrease and eventually end the use of animals for harmful research and testing. We work toward this goal by focusing on key areas such as eliminating cosmetics testing on animals through our Be Cruelty Free campaign, ending the use of dogs for testing, expanding the development and use of non-animal methods, and ensuring retirement of chimpanzees from laboratories to sanctuaries as soon as possible.
Established in 1993, ARDF promotes alternatives to the use of animals in biomedical research, testing and education. The foundation has awarded over $3.5M through its Annual Open Research Grant program. It also sponsors scientific meetings and presents the Cave Award for outstanding achievements in advancing alternative methods. ARDF recently launched the Alternatives in Research Challenge, a program to focus science funding and prize money exclusively in the area of alternative methods for biomedical research.